These data provide evidence that lumican evokes EMT/MET reprogramming in ERα knockdown cells, by suppressing the gene and protein levels of major EMT modulators in the mesenchymal, aggressive breast cancer cells. This evidence concerns the gene ESR1 and breast cancer.